戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  CCR2 as a viable therapeutic target for NF1 arterial stenosis.
2 sed for studies of neointima hyperplasia and arterial stenosis.
3  for TAG functional assessment of a coronary arterial stenosis.
4 no benefit in suppressing the development of arterial stenosis.
5 ve a predisposition for premature and severe arterial stenosis.
6 ial atherosclerosis increases with degree of arterial stenosis.
7 terial definition, venous contamination, and arterial stenosis.
8 nd progression of neointimal hyperplasia and arterial stenosis.
9 e to warfarin for patients with intracranial arterial stenosis.
10 n assessing the clinical importance of renal arterial stenosis.
11  assessed for location and extent of carotid arterial stenosis.
12 + cells did not correlate with the degree of arterial stenosis.
13 t contributes to the development of critical arterial stenosis.
14 k patients with atherosclerotic intracranial arterial stenosis.
15 timal proliferation in a murine model of NF1 arterial stenosis.
16 < .001), and for imaging of an area after an arterial stenosis (164 vs 7; P < .001).
17 Nf1 in myeloid cells amplified the degree of arterial stenosis after arterial injury.
18                In patients with intracranial arterial stenosis, aggressive medical management was sup
19  diarrhea, sphincter of Oddi dysfunction and arterial stenosis; all responded to directed treatments.
20 hologies associated with thrombosis, such as arterial stenosis and myeloproliferative neoplasms (MPNs
21  mild, transient graft damage due to gradual arterial stenosis and the development of arterial collat
22  for months to years; LMP causes progressive arterial stenosis and thrombosis and is composed of uniq
23 iovascular abnormalities, including pulmonic arterial stenosis and ventricular septal defects accompa
24 al and could lead to inaccuracies in carotid arterial stenosis assessment.
25 l MR DSA improves the delineation of carotid arterial stenosis by virtually eliminating saturation ef
26                                  Progressive arterial stenosis (cardiac allograft vasculopathy (CAV))
27 ozygous Nf1 (Nf1(+/-)) mice develop a marked arterial stenosis characterized by proliferating smooth
28 f renal transplant arteries and detection of arterial stenosis comparable with those at contrast-enha
29  grade and hemodynamic significance of renal arterial stenosis, diagnostic quality, and presence of a
30  VEC MR imaging at baseline, single coronary arterial stenosis, dipyridamole stress, and reactive hyp
31 y, reduces in-stent neointimal formation and arterial stenosis in hypercholesterolemic rabbits.
32 specificity (92%) for the detection of renal arterial stenosis, including all four distal stenoses en
33                                              Arterial stenosis is a nonneoplastic manifestation of NF
34                 Atherosclerotic intracranial arterial stenosis is an important cause of stroke that i
35                 Atherosclerotic intracranial arterial stenosis is an important cause of stroke.
36       As compared with kidneys without renal arterial stenosis, kidneys with renal arterial stenosis
37 hed definitions; FCA was defined as cerebral arterial stenosis not attributed to specific diagnoses s
38                         With MR angiography, arterial stenosis, occlusion, or tortuosity was identifi
39 ial plaque and an estimated internal carotid arterial stenosis of 50%-100%.
40 multiphoton microscopy revealed that in vivo arterial stenosis of a damaged carotid artery markedly i
41 a non-lacunar brain infarct without proximal arterial stenosis or cardioembolic sources, with a clear
42 flow reserve and (a) assessments of coronary arterial stenosis severity by quantitative coronary angi
43  renal arterial stenosis, kidneys with renal arterial stenosis showed 50% (0.14/0.28) EF reduction (P
44 ry groups, an approximately 50% reduction in arterial stenosis was observed with targeted NP treatmen
45      Antithrombotic therapy for intracranial arterial stenosis was recently evaluated in the Warfarin
46 0.44 to 3.57+/-0.65 and 3.45+/-0.58 mm2, and arterial stenosis was reduced from 58+/-11% to 37+/-8% a
47 nner in which clinically significant carotid arterial stenosis was reported varied widely.
48 icity of DSC CT for detecting 50% or greater arterial stenosis were calculated by using a bivariate s
49                Seven pigs with induced renal arterial stenosis were studied.
50 ading to graft loss, whereas two episodes of arterial stenosis were successfully treated with percuta
51 sal status is a risk factor for intracranial arterial stenosis when compared with premenopausal statu

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。